• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼吸道合胞病毒(RSV)对西班牙60岁及以上成年人的影响。

Impact of Respiratory Syncytial Virus (RSV) in Adults 60 Years and Older in Spain.

作者信息

Jimeno Ruiz Sara, Peláez Adrián, Calle Gómez Ángeles, Villarreal García-Lomas Mercedes, Martínez Silvina Natalini

机构信息

Departamento de Pediatría, Hospital HM Puerta del Sur, HM Hospitales, 28938 Madrid, Spain.

Unidad de Vacunas, HM Hospitales, 28938 Madrid, Spain.

出版信息

Geriatrics (Basel). 2024 Nov 6;9(6):145. doi: 10.3390/geriatrics9060145.

DOI:10.3390/geriatrics9060145
PMID:39584946
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11587121/
Abstract

: Respiratory illnesses frequently lead to hospitalization in adults aged 60 and older, especially due to respiratory viral infectious (RVI). This study investigates hospitalization patterns and characteristics of RVI at HM Hospitals from October 2023 to March 2024; : We retrospectively explored hospitalizations of patients aged 60 years and older with RVIs, gathering data on demographics, clinical profiles, comorbidities, and treatments. Outcomes included hospitalization, ICU admissions, and mortality, and independent factors associated with outcomes were identified using a multi-state model; : From October 2023 to March 2024, from a total of 3258 hospitalizations, 1933 (59.3%) were identified as positive for RVIs. Overall, SARS-CoV-2 was the most prevalent (52.6%), followed by influenza (32.7%), and RSV (11.8%). Most RVI involved single infections (88.2%). Hospitalization rates increased with age for SARS-CoV-2 (333.4 [95% CI: 295.0-375.2] to 651.6 [95% CI: 532.1-788.4]), influenza (169.8 [95% CI: 142.6-200.7] to 518.6 [95% CI: 412.1-643.1]), and RSV (69.2 [95% CI: 52.2-90.0] to 246.0 [95% CI: 173.8-337.5]), with SARS-CoV-2 showing the highest rate, followed by influenza and RSV. In the multi-state model, RSV infection significantly increased ICU admission risk (HR: 2.1, 95%, = 0.037). Age on admission (HR: 1.1, 95%, < 0.001) and Charlson score (HR: 1.4, 95%, = 0.001) were associated with transitioning from admission to death. ICU to death risks included age at admission (HR: 1.7, 95%, < 0.001); : RVI in adults 60 years and older are associated with high hospitalization and mortality rates, primarily driven by influenza and SARS-CoV-2, followed by RSV. Age and comorbidities significantly impact disease severity, emphasizing the need for targeted prevention and management strategies for RSV in this vulnerable population.

摘要

呼吸系统疾病经常导致60岁及以上成年人住院,尤其是由于呼吸道病毒感染(RVI)。本研究调查了2023年10月至2024年3月期间HM医院RVI的住院模式和特征:我们回顾性地探讨了60岁及以上患有RVI患者的住院情况,收集了人口统计学、临床特征、合并症和治疗方面的数据。结果包括住院、入住重症监护病房(ICU)和死亡率,并使用多状态模型确定与结果相关的独立因素;从2023年10月至2024年3月,在总共3258例住院病例中,1933例(59.3%)被确定为RVI阳性。总体而言,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)最为常见(52.6%),其次是流感(32.7%)和呼吸道合胞病毒(RSV,11.8%)。大多数RVI为单一感染(88.2%)。SARS-CoV-2、流感和RSV的住院率均随年龄增长而升高,SARS-CoV-2的住院率最高(333.4[95%置信区间:295.0 - 375.2]至651.6[95%置信区间:532.1 - 788.4]),其次是流感(169.8[95%置信区间:142.6 - 200.7]至518.6[95%置信区间:412.1 - 643.1])和RSV(69.2[95%置信区间:52.2 - 90.0]至246.0[95%置信区间:173.8 - 337.5])。在多状态模型中,RSV感染显著增加了入住ICU的风险(风险比:2.1,95%,P = 0.037)。入院时年龄(风险比:1.1,95%,P < 0.001)和查尔森评分(风险比:1.4,95%,P = 0.001)与从入院到死亡的转变相关。从ICU到死亡的风险包括入院时年龄(风险比:1.7,95%,P < 0.001);60岁及以上成年人的RVI与高住院率和死亡率相关,主要由流感和SARS-CoV-2引起,其次是RSV。年龄和合并症显著影响疾病严重程度,强调了针对这一脆弱人群制定RSV针对性预防和管理策略的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ced/11587121/0746e25091fb/geriatrics-09-00145-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ced/11587121/bfb86d1bca79/geriatrics-09-00145-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ced/11587121/274a664013f6/geriatrics-09-00145-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ced/11587121/0746e25091fb/geriatrics-09-00145-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ced/11587121/bfb86d1bca79/geriatrics-09-00145-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ced/11587121/274a664013f6/geriatrics-09-00145-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ced/11587121/0746e25091fb/geriatrics-09-00145-g003.jpg

相似文献

1
Impact of Respiratory Syncytial Virus (RSV) in Adults 60 Years and Older in Spain.呼吸道合胞病毒(RSV)对西班牙60岁及以上成年人的影响。
Geriatrics (Basel). 2024 Nov 6;9(6):145. doi: 10.3390/geriatrics9060145.
2
Burden of Respiratory Syncytial Virus-Associated Hospitalizations in US Adults, October 2016 to September 2023.美国成年人呼吸道合胞病毒相关住院负担,2016 年 10 月至 2023 年 9 月。
JAMA Netw Open. 2024 Nov 4;7(11):e2444756. doi: 10.1001/jamanetworkopen.2024.44756.
3
Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 years.65 岁及以上住院成年人中呼吸道合胞病毒与 SARS-CoV-2 和流感的严重程度比较。
J Infect. 2024 Nov;89(5):106292. doi: 10.1016/j.jinf.2024.106292. Epub 2024 Sep 26.
4
Severity of respiratory syncytial virus versus SARS-CoV-2 Omicron and influenza infection amongst hospitalized Singaporean adults: a national cohort study.新加坡住院成人中呼吸道合胞病毒与新冠病毒奥密克戎毒株及流感感染的严重程度:一项全国队列研究
Lancet Reg Health West Pac. 2025 Feb 20;55:101494. doi: 10.1016/j.lanwpc.2025.101494. eCollection 2025 Feb.
5
Characteristics and outcomes of patients hospitalized for infection with influenza, SARS-CoV-2 or respiratory syncytial virus in the season 2022/2023 in a large German primary care centre.2022/2023 年季节在一家德国大型初级保健中心住院治疗流感、SARS-CoV-2 或呼吸道合胞病毒感染的患者的特征和结局。
Eur J Med Res. 2023 Dec 6;28(1):568. doi: 10.1186/s40001-023-01482-z.
6
Focusing on severe infections with the respiratory syncytial virus (RSV) in adults: Risk factors, symptomatology and clinical course compared to influenza A / B and the original SARS-CoV-2 strain.重点关注成人严重呼吸道合胞病毒(RSV)感染:与甲型/乙型流感和原始 SARS-CoV-2 株相比的危险因素、症状和临床过程。
J Clin Virol. 2023 Apr;161:105399. doi: 10.1016/j.jcv.2023.105399. Epub 2023 Feb 14.
7
Acute Cardiac Events in Hospitalized Older Adults With Respiratory Syncytial Virus Infection.住院老年呼吸道合胞病毒感染患者的急性心脏事件。
JAMA Intern Med. 2024 Jun 1;184(6):602-611. doi: 10.1001/jamainternmed.2024.0212.
8
Adult Respiratory Syncytial Virus Infection: Defining Incidence, Risk Factors for Hospitalization, and Poor Outcomes, a Regional Cohort Study, 2016-2022.成人呼吸道合胞病毒感染:确定发病率、住院风险因素及不良结局,一项2016 - 2022年的区域队列研究
Pathogens. 2024 Aug 31;13(9):750. doi: 10.3390/pathogens13090750.
9
Respiratory syncytial virus hospitalization in middle-aged and older adults.中年及老年人呼吸道合胞病毒住院情况
J Clin Virol. 2017 Nov;96:37-43. doi: 10.1016/j.jcv.2017.09.001. Epub 2017 Sep 7.
10
Hospitalization cost estimates of respiratory syncytial virus and influenza infections in adults in Spain, 2016-2019.2016 - 2019年西班牙成人呼吸道合胞病毒和流感感染的住院费用估计
Vaccine. 2025 Feb 6;46:126683. doi: 10.1016/j.vaccine.2024.126683. Epub 2024 Dec 27.

引用本文的文献

1
Evaluating the efficacy, safety, and immunogenicity of FDA-approved RSV vaccines: a systematic review of Arexvy, Abrysvo, and mResvia.评估美国食品药品监督管理局(FDA)批准的呼吸道合胞病毒(RSV)疫苗的疗效、安全性和免疫原性:对Arexvy、Abrysvo和mResvia的系统评价
Front Immunol. 2025 Aug 18;16:1624007. doi: 10.3389/fimmu.2025.1624007. eCollection 2025.
2
Burden and Economic Impact of Respiratory Viral Infections in Adults Aged 60 and Older: A Focus on RSV.60岁及以上成年人呼吸道病毒感染的负担和经济影响:聚焦呼吸道合胞病毒
Diseases. 2025 Jan 28;13(2):35. doi: 10.3390/diseases13020035.